uni-leipzig-open-access/json/vaccines11040760

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T12:39:39Z","timestamp":1705667979889},"reference-count":30,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Vaccination rates are known to be low in patients with autoimmune inflammatory rheumatic diseases (AIIRD). We therefore aimed to determine current vaccination rates against influenza, Streptococcus pneumoniae and herpes zoster in a cohort of patients with AIIRD in Germany. Methods: Consecutive adult patients with an AIIRD were recruited from our outpatient clinic during their regular consultations. The individual vaccination status regarding influenza, Streptococcus pneumoniae and herpes zoster was obtained by reviewing the vaccination documents. Results: A total of 222 AIIRD patients (mean age 62.9 \u00b1 13.9 years) were included. In total, 68.5% were vaccinated against influenza, 34.7% against Streptococcus pneumoniae and 13.1% against herpes zoster (HZ). The pneumococcal vaccination was outdated in 29.4% of the vaccinated patients. Vaccination rates were significantly higher in patients \u226560 years old (odds ratio (OR) 2.167, 95% confidence interval (CI) 1.213\u20133.870, p = 0.008 for influenza, OR 4.639, 95% CI 2.555\u20138.422, p &lt; 0.0001 for pneumococcal and OR 6.059, 95% CI 1.772\u201320.712, p = 0.001 for HZ vaccination). Ages &gt; 60 years, female sex, glucocorticoid use and influenza vaccination were all independently associated with a pneumococcal vaccination. Regarding influenza vaccination, only a positive pneumococcal vaccination history remained independently associated. In patients with HZ vaccination, glucocorticoid use and a preceding pneumococcal vaccination were independently associated with HZ protection. Conclusions: The frequencies of vaccinations against influenza, Streptococcus pneumoniae and HZ have increased during recent years. While this can be partly explained by continuous efforts in patient education during the outpatient visits, the COVID-19 pandemic might also have contributed. Nevertheless, the persistently high incidence and mortality of these preventable diseases in patients with AIIRDs mandates further efforts to increase vaccination coverage, particularly in SLE patients.<\/jats:p>","DOI":"10.3390\/vaccines11040760","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T07:17:35Z","timestamp":1680160655000},"page":"760","source":"Crossref","is-referenced-by-count":2,"title":["Influenza, Pneumococcal and Herpes Zoster Vaccination Rates in Patients with Autoimmune Inflammatory Rheumatic Diseases"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"http:\/\/orcid.org\/0000-0002-1842-0754","authenticated-orcid":false,"given":"Marco","family":"Krasselt","sequence":"first","affiliation":[{"name":"Medical Clinic III, Endocrinology, Nephrology and Rheumatology, Leipzig University, Liebigstr. 20, 04103 Leipzig, Germany"}]},{"given":"Ulf","family":"Wagner","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Endocrinology, Nephrology and Rheumatology, Leipzig University, Liebigstr. 20, 04103 Leipzig, Germany"}]},{"given":"Olga","family":"Seifert","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Endocrinology, Nephrology and Rheumatology, Leipzig University, Liebigstr. 20, 04103 Leipzig, Germany"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00393-017-0410-5","article-title":"Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic","volume":"77","author":"Krasselt","year":"2018","journal-title":"Z. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00296-016-3608-y","article-title":"Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic","volume":"37","author":"Krasselt","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2018.04.063","article-title":"Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis","volume":"36","author":"Somes","year":"2018","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/jech-2011-200168","article-title":"Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: Record linkage cohort analyses","volume":"66","author":"Wotton","year":"2012","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Blumentals, W.A., Arreglado, A., Napalkov, P., and Toovey, S. (2012). Rheumatoid arthritis and the incidence of influenza and influenza-related complications: A retrospective cohort study. BMC Musculoskelet. Disord., 13.","DOI":"10.1186\/1471-2474-13-158"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s10067-019-04563-9","article-title":"Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis","volume":"38","author":"Krasselt","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Krasselt, M., Baerwald, C., Liebert, U.G., and Seifert, O. (2021). Humoral Immunity to Varicella Zoster Virus in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Compared to Healthy Controls. Vaccines, 9.","DOI":"10.3390\/vaccines9040325"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","unstructured":"RKI (2022). St\u00e4ndige Impfkommission: Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut 2022. Epidemiol. Bull., 4, 3\u201366."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Schmedt, N., Schiffner-Rohe, J., Sprenger, R., Walker, J., von Eiff, C., and Hackl, D. (2019). Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220848"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/rheumatology\/key120","article-title":"Vaccination coverage in systemic lupus erythematosus-a cross-sectional analysis of the German long-term study (LuLa cohort)","volume":"57","author":"Chehab","year":"2018","journal-title":"Rheumatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s42358-021-00197-1","article-title":"Influenza and pneumococcal vaccination coverage in Latin American patients with systemic lupus erythematosus: A cross-sectional and comparative study","volume":"61","author":"Chiganer","year":"2021","journal-title":"Adv. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3899\/jrheum.181376","article-title":"Suboptimal Immunization Coverage among Canadian Rheumatology Patients in Routine Clinical Care","volume":"47","author":"Qendro","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/acr2.11427","article-title":"Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis Cohort","volume":"4","author":"Ta","year":"2022","journal-title":"ACR Open Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00296-021-04817-3","article-title":"Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the COVID-19 pandemic: A cross-sectional study","volume":"41","author":"Fragoulis","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3899\/jrheum.200806","article-title":"Improving Pneumococcal Vaccination Rates in Rheumatology Patients by Using Best Practice Alerts in the Electronic Health Records","volume":"48","author":"Sheth","year":"2021","journal-title":"J. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"SI180","DOI":"10.1093\/rheumatology\/keac089","article-title":"Humoral and Cellular Response to COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases under Real-life Conditions","volume":"61","author":"Krasselt","year":"2022","journal-title":"Rheumatology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Krasselt, M., Baerwald, C., and Seifert, O. (2022). COVID-19 Vaccination Coverage in Patients with Rheumatic Diseases in a German Outpatient Clinic: An Observational Study. Vaccines, 10.","DOI":"10.3390\/vaccines10020253"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ajic.2021.02.012","article-title":"Impact of the influenza vaccine on COVID-19 infection rates and severity","volume":"49","author":"Conlon","year":"2021","journal-title":"Am. J. Infect. Control"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e001499","DOI":"10.1136\/rmdopen-2020-001499","article-title":"Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study","volume":"7","author":"Kiltz","year":"2021","journal-title":"RMD Open"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Weycker, D., Farkouh, R.A., Strutton, D.R., Edelsberg, J., Shea, K.M., and Pelton, S.I. (2016). Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions. BMC Health Serv. Res., 16.","DOI":"10.1186\/s12913-016-1432-4"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/civ803","article-title":"Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs","volume":"62","author":"Shigayeva","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Backhaus, E., Berg, S., Andersson, R., Ockborn, G., Malmstrom, P., Dahl, M., Nasic, S., and Trollfors, B. (2016). Epidemiology of invasive pneumococcal infections: Manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1648-2"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e001235","DOI":"10.1136\/rmdopen-2020-001235","article-title":"Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis","volume":"7","author":"Riley","year":"2021","journal-title":"RMD Open"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.vaccine.2014.02.002","article-title":"Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults 60\u201364 years of age","volume":"32","author":"Greenberg","year":"2014","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.vaccine.2013.04.084","article-title":"Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"Herpes Zoster Vaccines","volume":"224","author":"Harbecke","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"Elkayam","year":"2011","journal-title":"Ann. Rheum. Dis."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/4\/760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T16:34:04Z","timestamp":1698165244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/4\/760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["vaccines11040760"],"URL":"http:\/\/dx.doi.org\/10.3390\/vaccines11040760","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":["Pharmacology (medical)","Infectious Diseases","Drug Discovery","Pharmacology","Immunology"],"published":{"date-parts":[[2023,3,29]]}}}